Results 241 to 250 of about 181,578 (308)
Application and Challenges of Chimeric Antigen Receptor T Cell Therapy in Systemic Rheumatic Diseases and Autoimmune Disorders. [PDF]
Fan Z, Zhang L, Yu H.
europepmc +1 more source
bacNeo: A Computational Toolkit for Identifying Bacteria‐Derived Neoantigens in Human Cancers
We present bacterial neoantigen (bacNeo), a multi‐omics‐based computational software to classify bacterial components (BACC), type bacteria‐bound HLA alleles (BACH), and prioritize bacterial peptides as neoantigens (BACP). Bacterial neoantigen potential is quantified by score for peptide antigenicity recognition & kinetics (SPARK), enabling ...
Yunzhe Wang +5 more
wiley +1 more source
Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma. [PDF]
Malek E +6 more
europepmc +1 more source
This illustration integrates key concepts covered in the review, including high‐risk populations, viral structure, host entry factors, the replication cycle, and licensed antibody‐based prevention strategies. ABSTRACT Respiratory syncytial virus (RSV) is a negative‐sense RNA virus belonging to the genus Orthopneumovirus within the family Pneumoviridae.
Zekai Cheng +3 more
wiley +1 more source
ABSTRACT Human papillomavirus (HPV) is a double‐stranded DNA virus that infects human skin and mucosal tissues exclusively. The German scientist Harald zur Hausen was awarded the 2008 Nobel Prize in Physiology or Medicine for his discovery of the link between HPV infection and cervical cancer.
Fang Zhu +5 more
wiley +1 more source
Patients' and caregivers' perspectives on preparedness for and experience with chimeric antigen receptor T-cell therapy. [PDF]
Barata A +9 more
europepmc +1 more source
SUMOylation, a dynamic post‐translational modification, acts as a master regulator at the heart of tumor malignancy. Our work delineates how the SUMOylation cycle—mediated by E1/E2/E3 enzymes and reversed by SENPs—orchestrates multiple hallmarks of cancer. The central pathway converges on three critical pathological axes: 1.
Yimao Wu +6 more
wiley +1 more source
Operationalizing Access for Chimeric Antigen Receptor T cell Therapies: A Cross-functional Perspective. [PDF]
Singh S +5 more
europepmc +1 more source
CXCR3 enhanced murine chimeric antigen receptor T cells in the treatment of solid tumors. [PDF]
Zhang X +5 more
europepmc +1 more source

